Search

Your search keyword '"Sahin, Deniz"' showing total 228 results

Search Constraints

Start Over You searched for: Author "Sahin, Deniz" Remove constraint Author: "Sahin, Deniz" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
228 results on '"Sahin, Deniz"'

Search Results

1. Building Timely Consensus Among Diverse Stakeholders: An Adapted Nominal Group Technique

Catalog

Books, media, physical & digital resources

5. The COVID-19 Pandemic and Dementia: a Multijurisdictional Meta-Analysis of the Impact of the First Two Pandemic Waves on Acute Health-care Utilization and Mortality in Canada.

6. Virtual primary care for people living with dementia in Canada: cross-sectional surveys of patients, care partners, and family physicians.

8. Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience

10. A comparison of the prognostic performance of the Lugano 2014 and RECIL 2017 response criteria in patients with NHL from the phase III GOYA and GALLIUM trials

13. METHODS FOR ESTIMATING MULTIREGIONAL INPUT-OUTPUT-TABLES

14. Measuring Potentially Avoidable Acute Care Transfers From Long-Term Care Homes in Quebec: a Cross Sectional Study.

15. Anti-inflammatory effects of montelukast on smoke-induced lung injury in rats

16. A prognostic model integrating PET‐derived metrics and image texture analyses with clinical risk factors from GOYA

17. Geriatric dementia care at Ontario Shores: A new model of care

18. How Does The Pandemic Affect Older Adults Mental Health?

21. Changes in Ambulatory Physician Visits Among Community-Dwelling Persons Living with Dementia During the First Two Waves of the COVID-19 Pandemic in Three Canadian Provinces.

22. Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study

26. Additional file 1 of A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA

27. YAŞLI BİREYLERİN SAĞLIK HİZMETİ KULLANIMININ BAZI DEĞİŞKENLER AÇISINDAN İNCELENMESİ: KESİTSEL BİR ARAŞTIRMA

28. Yaşlı Evde Bakım Hastaları Risk Değerlendirme Ölçeği Geliştirme Çalışması

33. Final Analysis of GOYA: A Randomized, Open-Label, Phase III Study of Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

35. Patient-Level Meta-Analysis of End-of-Therapy PET-CR as a Surrogate Endpoint for PFS and OS in Patients with Previously Untreated DLBCL: Implications for Clinical Trial Design

36. A Fully Automated Measurement of Total Metabolic Tumor Burden in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

37. Complete Response Status According to RECIL 2017 Criteria Shows High Concordance with Lugano 2014 Criteria and Is Highly Prognostic for Outcome in Previously Untreated Patients with CD20-Positive Diffuse Large B-Cell Lymphoma (DLBCL)

38. A Prognostic Model Integrating PET-Derived Quantitative Parameters and Image Texture Analyses Using Radiomics in a Large Prospective Phase III Trial, GOYA

39. Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy

40. Experiences of an Emergency Department Visit Among Older Adults and Their Families: Qualitative Findings From a Mixed-Methods Study

41. Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy

42. MOESM1 of Enhancement of docosahexaenoic acid (DHA) production from Schizochytrium sp. S31 using different growth medium conditions

45. Bone Marrow Biopsy Impacts Response Assessment in a Minority of Patients with Follicular Lymphoma and Diffuse Large B-Cell Lymphoma Treated with Immunochemotherapy: Results from the Randomized Phase III GALLIUM and GOYA Trials

46. Baseline PET-Derived Metabolic Tumor Volume Metrics Did Not Predict Outcomes in Follicular Lymphoma Patients Treated with First-Line Immunochemotherapy and Antibody Maintenance in the Phase III GALLIUM Study